We report a pediatric patient with chronic idiopathic thrombocytopenic purpura who suffered from an influenza A (H1N1) virus infection. A 13-year-old girl presented with fever, coughing, and generalized petechiae. The influenza A antigen was positive in her pharyngeal aspirate. She was successfully treated with neuraminidase inhibitor oseltamivir phosphate. Her platelet counts progressively increased with oseltamivir phosphate without another blood product or agent. We suggest that oseltamivir phosphate can be used in patients with immune thrombocytopenic purpura who present with influenza virus A infection. We also suggest that oseltamivir phosphate can be effective in patients with immune thrombocytopenic purpura. Large study groups are needed to confirm the relationship between idiopathic thrombocytopenic purpura and neurominidase inhibitors.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000321379 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Synthesis and evaluation of anti-Giardia activity of oseltamivir analogs.
Bioorg Med Chem Lett
February 2025
Center for Drug Design, Academic Health Center, University of Minnesota, Minneapolis, MN 55455, United States. Electronic address:
We reported earlier that oseltamivir (Osm, Tamiflu®), an anti-viral agent, inhibits the attachment of trophozoites to intestinal epithelial cells and cyst production in culture. Osm also disassembles lipid rafts (LRs) and the biogenesis of extracellular vesicles (EVs) by Giardia. In the current study, we synthesized forty-one Osm analogs with the derivatization of oseltamivir phosphate.
View Article and Find Full Text PDFOseltamivir phosphate (Tamiflu) alters neurobehavior of zebrafish larvae by inducing mitochondrial dysfunction.
Sci Total Environ
December 2024
Gansu Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, School of Life Sciences, Lanzhou University, No. 222 South Tianshui Road, Lanzhou 730000, Gansu Province, China. Electronic address:
Antiviral drugs are widely used, yet their potential risks during early development, particularly within the central nervous system, remain contentious. Oseltamivir phosphate (OSE), a commonly prescribed antiviral, is increasingly detected in various environments. However, its toxicity to organisms and the underlying mechanisms are not well understood.
View Article and Find Full Text PDFUPLC-PDA factorial design assisted method for simultaneous determination of oseltamivir, dexamethasone, and remdesivir in human plasma.
Sci Rep
September 2024
Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.
A green and simple UPLC method was developed and optimized, adopting a factorial design for simultaneous determination of oseltamivir phosphate and remdesivir with dexamethasone as a co-administered drug in human plasma and using daclatasvir dihydrochloride as an internal standard within 5 min. The separation was established on UPLC column BEH C 1.7 μm (2.
View Article and Find Full Text PDFFactors Associated With Nonprescription of Oseltamivir for Infant Influenza Over 9 Seasons.
J Pediatric Infect Dis Soc
September 2024
Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Article Synopsis
- The CDC recommends oseltamivir phosphate for infants under 2 years with confirmed or suspected influenza, as they face high risks for complications.
- A 9-year study at the University of Pittsburgh Medical Center analyzed 457 infants under 12 months and found 86% were prescribed oseltamivir, with prescription rates increasing from 64.6% to 90.4% over two time periods.
- Factors leading to nonprescription included longer symptom duration, earlier diagnosis years, positive multiplex PCR tests, and lack of fever at the doctor's visit, indicating potential areas for improving prescribing practices.
Interaction mechanism of oseltamivir phosphate with bovine serum albumin: multispectroscopic and molecular docking study.
BMC Chem
July 2024
School of Physical Science & Technology, Guangxi University, Nanning, 530004, China.
Oseltamivir phosphate (OP) is an antiviral drug with potential risks to human health due to overuse, leading to serious consequences such as gastrointestinal disturbances, abnormal neuropsychiatric symptoms, and sudden death. Therefore, gaining an in-depth understanding of its interaction with proteins is crucial. We investigated the interaction between OP and bovine serum albumin (BSA) utilizing multispectral methods (i.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!